Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model (Q33981712)

30 July 2017

Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model (English)

1 reference

30 July 2017

1 reference

1 reference

1 reference

D Andes

1

1 reference

30 July 2017

T Stamsted

series ordinal

2

1 reference

30 July 2017

R Conklin

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

30 July 2017

5

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

30 July 2017

45

1 reference

30 July 2017

922-926

1 reference

30 July 2017

3

1 reference

Amphotericin B and fluconazole affect cellular charge, macrophage phagocytosis, and cellular morphology of Cryptococcus neoformans at subinhibitory concentrations

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90394

Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90394

Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90394

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90394

International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90394

Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90394

Antifungal agents: chemotherapeutic targets and immunologic strategies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90394

Correlation between in vitro and in vivo activity of antifungal agents against Candida species

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90394

Detection of amphotericin B-resistant Candida isolates in a broth-based system

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90394

Comparative pharmacokinetics of Sch 28191 and amphotericin B in mice, rats, dogs, and cynomolgus monkeys

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90394

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90394

Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90394

Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90394

Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90394

Experimental antifungal chemotherapy in granulocytopenic animal models of disseminated candidiasis: approaches to understanding investigational antifungal compounds for patients with neoplastic diseases

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90394

In vivo postantibiotic effect in a thigh infection in neutropenic mice

5 July 2018

1 reference

12 December 2020

Hospital-acquired candidemia. The attributable mortality and excess length of stay

1 reference

12 December 2020

Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System

1 reference

12 December 2020

The postantibiotic effect of antifungal agents against common pathogenic yeasts

1 reference

12 December 2020

Comparison of fluconazole, amphotericin B and flucytosine in treatment of a murine model of disseminated infection with Candida glabrata in immunocompromised mice

1 reference

12 December 2020

A pharmacologic guide to the clinical use of amphotericin B

1 reference

12 December 2020

Chemical and antigenic alterations of Candida albicans cell walls related to the action of amphotericin B sub-inhibitory doses

1 reference

12 December 2020

10.1128/AAC.45.3.922-926.2001

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference